10-K Decoder · All companies

PTC Therapeutics, Inc.

PTCT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$1.73B$807M+115%
Operating income$867M−$303M
Net income$683M−$363M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 29, 2026

$Q3 2026Year earlierChange
Revenue$358M$211M+69.6%
Operating income$25.1M$3.00M+737%
Net income−$51.7M$15.9M

Q3 2026 dashboardQ3 2026 infographic

Questions

What was PTC Therapeutics's revenue in FY2025?
$1.73B in FY2025 (Fiscal year ended Dec 31, 2025), +115% vs $807M a year earlier, per its 10-K filed Feb 2026.
Was PTC Therapeutics profitable in FY2025?
Yes: net income was $683M and operating income $867M in FY2025.
What was PTC Therapeutics's revenue in Q3 2026?
$358M (+69.6% vs a year earlier), per its Form 10-Q filed Oct 29, 2026.